Mouwasat Medical Services Company — Cyborg Score 7/10
Strong
Healthcare Services / Private Hospital Operations
Strategic Profile
The company operates in two segments—Medical Services (majority revenue) and Pharmaceuticals—providing integrated healthcare delivery. Mouwasat operates specialized centers including long-term care, rehabilitation, cardiology, and fertility services across approximately 9 branches with key subsidiaries including Eastern Medical Services Company Limited and Jeddah Doctors Company.
Cyborg Score Rationale
Mouwasat commands a $3.57B market cap with trailing 12-month revenue of $824M as of September 2025. The company demonstrates solid fundamentals with geographic diversification across Saudi Arabia's major cities and a stable dividend yield of 4.42%, though it faces competition from established players in the growing Saudi healthcare market.
Top Insights
Mouwasat is executing SAR 1.3 billion hospital expansion initiatives across Saudi Arabia
Recent joint venture with Modawa and Rieaya Medical formed in June 2024 indicates strategic partnership expansion
Established major healthcare provider presence in Eastern Province with nationwide insurance network relationships
Operating ~9 branches with strong regional footprint in Dammam, Riyadh, Khobar, Jubail, Madinah and Qatif
Named Competitors
Dr Sulaiman Al Habib Medical Services Group — Large-scale Saudi private hospital network operator
Recent Developments
(January 2026) Announced establishment of new hospital in Riyadh Al-Narjis District
(December 2025) Progress update on Mouwasat Hospital construction in Yanbu Industrial City
(June 2024) Joint venture formation with Modawa and Rieaya Medical
Open the full interactive Mouwasat Medical Services Company report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.